Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Short-term Investments (2016 - 2024)

Historic Short-term Investments for Cytosorbents (CTSO) over the last 4 years, with Q4 2024 value amounting to $5.0 million.

  • Cytosorbents' Short-term Investments changed N/A to $5.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.0 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2024, which is N/A changed from last year.
  • As of Q4 2024, Cytosorbents' Short-term Investments stood at $5.0 million.
  • Cytosorbents' Short-term Investments' 5-year high stood at $5.0 million during Q4 2024, with a 5-year trough of $5.0 million in Q4 2024.